Improved detection of synthetic lethal interactions in Drosophila cells using variable dose analysis (VDA)

Area of Science:

• Oncology
• Genetics
• Pharmacology

Background:

• Synthetic sick/lethal (SS/L) screens identify potential anti-cancer drug targets but often lack consistency.
• Essential genes involved in SS/L interactions can be missed due to high knockdown efficiency of RNAi reagents.

Purpose of the Study:

• To develop a more sensitive and reproducible assay for detecting SS/L interactions.
• To identify SS/L interactions involving TSC1 and TSC2 tumor suppressors.
• To discover potential drug repurposing candidates for TSC-related tumors.

Main Methods:

• Developed Variable Dose Analysis (VDA) to measure cell viability across a range of knockdown efficiencies.
• Applied VDA to screen for SS/L interactions with TSC1 and TSC2.
• Constructed a SS/L interaction network for TSC.

Main Results:

• VDA demonstrated high sensitivity and reproducibility in detecting SS/L interactions.
• Identified a SS/L network for TSC1/TSC2.
• Discovered four FDA-approved drugs that selectively impact TSC-deficient cells.

Conclusions:

• VDA is a robust method for discovering SS/L interactions, overcoming limitations of previous screens.
• The identified SS/L network and drug candidates offer new therapeutic strategies for TSC-related tumors.
• Drug repurposing holds promise for treating rare genetic tumor syndromes.